Liposarcoma is cancer of connective that occurs in the fat cells of the body. It accounts for up to 18% of all soft tissue sarcomas. Liposarcoma can occur in almost any part of the body, but more than half of liposarcoma cases involve the thigh, and up to a third involve the abdominal cavity. Liposarcoma tends to affects adults between the ages of 40 and 60. 5 categories of liposarcomas are Well-differentiated liposarcoma, Myxoid liposarcoma, Pleomorphic liposarcoma, Dedifferentiated liposarcoma, round cell Some of the common symptoms are lump (which can be soft or firm to the touch) that is usually painless and slow growing . But tumors in the abdomen can grow to be quite large before they are found.
Diagonosis is done with the help of Imaging tests that often includes an X-ray and an MRI. An experienced radiologist might suspect the diagnosis based on the results of these tests.Needle and surgical biopsy is planned by a surgeon experienced with sarcomas. The treatment for primary liposarcomas that have not yet spread to other organs is Surgery. Amputation is also one of the way to completely remove the cancer and restore the patient to a functional life. To prevent recurrence at the surgical site, combination of surgery and radiation therapy is done.Statistics for Canadians are about 475 died since 2010 out of which 235 were men and 240 women.
For Cholangiocarcinoma, Resection is an option in cholangiocarcinoma, but less than 30% of cases of cholangiocarcinoma are resectable at diagnosis. For Hepatoblastoma, Removing the tumor by either surgical resection or liver transplant can be used in the treatment of hepatoblastoma. In some cases surgery can offer a cure. Chemotherapy may be used before and after surgery and transplant.Prevention of cancers can be separated into primary, secondary and tertiary prevention. Primary prevention preemptively reduces exposure to a risk factor for liver cancer. One of the most successful primary liver cancer preventions is vaccination against hepatitis B. Vaccination for hepatitis C virus is currently unavailable. Death rate for Liver cancer in France is 7.56